Huang et al reported that the Na+/K+-ATPase inhibitor, ursolic acid, inhibited the invasion and migration of lung cancer cells by decreasing the activity of VEGF, MMP and ICAM-1 (23). This evidence concerns the gene VEGFA and lung carcinoma.